|Articles|December 1, 2001
AREDS research is 'another step forward' for AMD
For many retinal specialists and their patients, the results of the Age-RelatedEye Disease Study (AREDS)-released by the National Eye Institute (NEI) ofthe National Institutes of Health in mid-October-are welcome news in thebattle to slow the progression of age-related macular degeneration (AMD).
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Last year in glaucoma at EnVision Summit 2025
4
Looking back at the 2025 EnVision Summit
5
























